In 174 adults on daily PPIs without a chronic indication at three Dutch hospitals, an app-based discontinuation tool led more to stop PPIs at 2 months than a brochure (86% vs 64% of 163 analysed; RR 1.34, 95% CI 1.11–1.61). Adverse events were similar.
RCTn = 174
Koggel et al. An App-Based Proton Pump Inhibitor Discontinuation Tool: A Multicentre, Open-Label, Randomised Superiority Trial